» Articles » PMID: 23889619

Intestinal Microbiota; Relevance to Obesity and Modulation by Prebiotics and Probiotics

Overview
Journal Nutr Hosp
Date 2013 Jul 30
PMID 23889619
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The intestinal microbiota has several beneficial functions related to host health. Studies suggest that it may be related to the presence of metabolic diseases, including obesity.

Objective: A bibliographic survey was carried out upon the relationship between the intestinal microbiota and obesity and the possible impacts of the use of prebiotics and probiotics, aiming to understand this complex and promising interaction.

Methods: A search was conducted in the Lilacs, PubMed, SciElo and ScienceDirect databases, using the keywords "gut microbiota" and "obesity".

Results And Discussion: We identified 613 original studies. After careful selection, 61 original articles were included in this review. The others indicated that there are differences in the microbial composition between obese and non-obese patients and the possible mechanisms involved. Alteration is caused in the energy homeostasis, in the use of dietary intake and storage of lipids due to the composition of the intestinal microbiota. Among the studies that evaluated the microbiota modulation, seven used probiotics; 24 used prebiotics, and five studies were performed using food. After dietary manipulation, the growth of bifidobacteria was obtained in 10 studies, in association with weight reduction, adipogenic effects of diet, intestinal permeability and inflammatory markers.

Conclusion: Knowledge on the impact of the microbiota on metabolic pathways allows to conceive new factors associated with obesity and modulation by prebiotics and probiotics. In this sense, the main effect observed was the increase in bifidobacteria, usually accompanied by weight loss and enhancement of parameters related to obesity.

Citing Articles

The effect of probiotics, prebiotics and synbiotics on gut microbial community profile in overweight and obese Latin American and Caribbean populations: a systematic review of human trials.

Bineid M, Liu L, Ventura E, Bansal S, Curi-Quinto K, Del Valle-Mendoza J Gut Microbiome (Camb). 2025; 6:e2.

PMID: 39944116 PMC: 11810601. DOI: 10.1017/gmb.2024.12.


Modulatory Effects of Multi-species/Multi-strain Synbiotic and L-carnitine Concomitant Supplementation on Atherogenic-Indices, Body Composition, Visceral Obesity, and Appetite in Metabolically Healthy Women with Obesity: A Double-Blind Randomized....

Fallah F, Mahdavi R Probiotics Antimicrob Proteins. 2025; .

PMID: 39921845 DOI: 10.1007/s12602-025-10460-2.


Efficacy and Safety of WCFA19 ( WIKIM51) in Reducing Body Fat in Overweight and Obese Adults.

Sun H, Shin J, Kim M, Bae S, Lee N, Yoo B J Clin Med. 2024; 13(9).

PMID: 38731087 PMC: 11084377. DOI: 10.3390/jcm13092559.


The Role of Peptides in Asthma-Obesity Phenotype.

Russjan E Int J Mol Sci. 2024; 25(6).

PMID: 38542187 PMC: 10970696. DOI: 10.3390/ijms25063213.


Obesity-related asthma and its relationship with microbiota.

Huang J, Zhou X, Dong B, Tan H, Li Q, Zhang J Front Cell Infect Microbiol. 2024; 13:1303899.

PMID: 38292857 PMC: 10825962. DOI: 10.3389/fcimb.2023.1303899.